have to say thanks for the analysis here. I bought in 1.5m on the back of your work at .014. even then I was sceptical when it had gone up from.012. thanks
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%